Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

VNRX

VolitionRX (VNRX)

VolitionRX Limited
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:VNRX
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202422h29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:VNRXVolitionRX Limited
13/05/202422h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:VNRXVolitionRX Limited
13/05/202422h13Edgar (US Regulatory)Form 8-K - Current reportAMEX:VNRXVolitionRX Limited
13/05/202422h10PR Newswire (US)VolitionRx Limited Announces First Quarter 2024 Financial Results and Business UpdateAMEX:VNRXVolitionRX Limited
08/05/202414h00PR Newswire (US)VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business UpdateAMEX:VNRXVolitionRX Limited
23/04/202414h00PR Newswire (US)Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through AntechAMEX:VNRXVolitionRX Limited
26/03/202412h21IH Market NewsU.S. Index Futures on the Rise, Oil Prices Show StabilityAMEX:VNRXVolitionRX Limited
25/03/202421h10PR Newswire (US)VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business UpdateAMEX:VNRXVolitionRX Limited
21/03/202413h30PR Newswire (US)VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business UpdateAMEX:VNRXVolitionRX Limited
20/03/202413h30PR Newswire (US)Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in JapanAMEX:VNRXVolitionRX Limited
19/03/202421h30PR Newswire (US)Volition appoints Dr Andrew Retter as Chief Medical OfficerAMEX:VNRXVolitionRX Limited
14/02/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:VNRXVolitionRX Limited
09/02/202421h56Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:VNRXVolitionRX Limited
02/02/202414h00PR Newswire (US)Volition to Share Nu.Q® NETs Strategy Update at Upcoming WebinarAMEX:VNRXVolitionRX Limited
26/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
26/01/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
 Showing the most relevant articles for your search:AMEX:VNRX